Beta
Back to DELL.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
eps-chart

DELL EPS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for DELL's EPS in Q4'26 shows a strong performance of 3.38 USD, marking a significant increase from the previous quarter's 2.31 USD in Q3'26 and reflecting robust profitability growth over the fiscal year. Over the period from Q1'24 to Q4'26, DELL's EPS has exhibited an overall upward trend, rising from 0.81 USD to 3.38 USD, with notable volatility including a dip to 0.64 USD in Q2'24 followed by consistent recovery and peaks in Q3'24 (1.39 USD) and Q4'26. Year-over-year EPS growth has been positive in most quarters, averaging around 0.44% in the later periods, though early quarters showed mixed results with a sharp 308.82% surge in Q3'24 offsetting initial declines of -42.96% in Q1'24. This bar and line chart highlights improving earnings momentum, driven by sustained growth in recent fiscal years. ### Key Data Points | Fiscal Period | EPS (USD) | EPS Growth (YoY %) | |---------------|-----------|---------------------| | Q1'24 | 0.81 | -42.96 | | Q2'24 | 0.64 | -7.25 | | Q3'24 | 1.39 | 308.82 | | Q4'24 | 1.63 | 89.53 | | Q1'25 | 1.36 | 67.90 | | Q2'25 | 1.19 | 85.94 | | Q3'25 | 1.61 | 15.83 | | Q4'25 | 2.35 | 44.17 | | Q1'26 | 1.39 | 2.21 | | Q2'26 | 1.72 | 44.54 | | Q3'26 | 2.31 | 43.48 | | Q4'26 | 3.38 | 43.83 | This analysis focuses on the provided quarterly data, emphasizing trends suitable for financial review.